Semaglutide and a similar compound, tirzepatide, had been on the FDA’s shortages list since 2022, and the popularity of the ...
More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...
The company's semaglutide injection—better known by the brand names Ozempic and Wegovy—has become well-known for its weight-loss results and ability to manage diabetes. And while there are several ...
The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...
While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...
Hims & Hers suffered a deep pullback in August after the FDA removed semaglutide from its shortage list (compound makers can ...
Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths ...